SAVIENT PHARMACEUTICALS INC·4

Feb 15, 6:02 PM ET

Hamelin Paul 4

4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 15, 2011

Insider Transaction Report

Form 4
Period: 2011-02-14
Hamelin Paul
President
Transactions
  • Sale

    Common Stock, $.01 par value per share

    2011-02-14$9.89/sh5,371$53,117124,765 total
Footnotes (1)
  • [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 13, 2009.

Documents

1 file
  • 4
    rrd301491.xmlPrimary

    P HAMELIN FORM 4